BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9869633)

  • 1. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis.
    Xiao Q; Claassen G; Shi J; Adachi S; Sedivy J; Hann SR
    Genes Dev; 1998 Dec; 12(24):3803-8. PubMed ID: 9869633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.
    Park DS; Razani B; Lasorella A; Schreiber-Agus N; Pestell RG; Iavarone A; Lisanti MP
    Biochemistry; 2001 Mar; 40(11):3354-62. PubMed ID: 11258956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
    EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of gadd45 by C/EBP alpha and c-Myc.
    Tao H; Umek RM
    DNA Cell Biol; 1999 Jan; 18(1):75-84. PubMed ID: 10025511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.
    Bush A; Mateyak M; Dugan K; Obaya A; Adachi S; Sedivy J; Cole M
    Genes Dev; 1998 Dec; 12(24):3797-802. PubMed ID: 9869632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
    Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
    Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel Krüppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activity.
    Hennemann H; Vassen L; Geisen C; Eilers M; Möröy T
    J Biol Chem; 2003 Aug; 278(31):28799-811. PubMed ID: 12748187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
    Aziz N; Cherwinski H; McMahon M
    Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein.
    Kinoshita T; Shirasawa H; Shino Y; Moriya H; Desbarats L; Eilers M; Simizu B
    Virology; 1997 May; 232(1):53-61. PubMed ID: 9185588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the N-terminal domain of the Myc oncoprotein.
    Oster SK; Mao DY; Kennedy J; Penn LZ
    Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation.
    Nilsson JA; Maclean KH; Keller UB; Pendeville H; Baudino TA; Cleveland JL
    Mol Cell Biol; 2004 Feb; 24(4):1560-9. PubMed ID: 14749372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPalpha regulation of the growth-arrest-associated gene gadd45.
    Constance CM; Morgan JI; Umek RM
    Mol Cell Biol; 1996 Jul; 16(7):3878-83. PubMed ID: 8668205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of c-Myc-induced apoptosis by p53.
    Hermeking H; Eick D
    Science; 1994 Sep; 265(5181):2091-3. PubMed ID: 8091232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC.
    Wu KJ; Polack A; Dalla-Favera R
    Science; 1999 Jan; 283(5402):676-9. PubMed ID: 9924025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
    Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
    Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.